5414x [ 2K 2025 ]

The full regulatory document can be accessed through the London Stock Exchange or financial news platforms like ADVFN . Interim results for the 6 months ended 30 June 25

: Continued advancement in national programs like NIHR Bioresource. Strategic and Operational Developments The full regulatory document can be accessed through

: 58.2%, slightly down from 58.8% in H1 2024 due to one-off inventory charges and currency headwinds, despite an underlying improvement of 525 basis points. Segment Growth : The full regulatory document can be accessed through

: Introduced next-generation automated flow cell lines and strengthened quality assurance to ISO 13485 standards. The full regulatory document can be accessed through

: Completed a programme resulting in an approximately 5% reduction in workforce to reallocate capital to growth areas.